Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Loebinger

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Thorax|April 15, 2010
Stem cells as vectors for antitumour therapyMichael R Loebinger, Sam M Janes
Seminars in Respiratory and Critical Care Medicine|July 14, 2021
Clinical and Radiological Phenotypes and EndotypesRicardo J José, Michael R Loebinger
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Diagnosis of Nontuberculous Mycobacteria Lung DiseaseSteven A Cowman, Michael R Loebinger
The Lancet. Respiratory Medicine|December 4, 2014
Non-cystic fibrosis bronchiectasis: an evidence-base for new therapiesDiana Bilton, Michael R Loebinger, Robert Wilson
Future Healthcare Journal|August 5, 2022
The role of wirelessly observed therapy in improving treatment adherenceKartik Kumar, Michael R Loebinger, Saira Ghafur
Clinical Science (London, England : 1979)|December 8, 2007
Therapeutic potential of stem cells in lung disease: progress and pitfallsMichael R Loebinger, Susana Aguilar, Sam M Janes
Thorax|December 18, 2012
Research priorities in bronchiectasisAnthony De Soyza, Jeremy Stuart Brown, Michael R Loebinger, et al.
Proceedings of the American Thoracic Society|August 8, 2008
Mesenchymal stem cells as vectors for lung diseaseMichael R Loebinger, Elizabeth K Sage, Sam M Janes
Cancer Research|May 14, 2009
Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancerMichael R Loebinger, Ayad Eddaoudi, Derek Davies, et al.
The European Respiratory Journal|June 22, 2019
Non-tuberculous mycobacterial pulmonary diseaseSteven Cowman, Jakko van Ingen, David E Griffith, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Thorax|April 15, 2010
Stem cells as vectors for antitumour therapyMichael R Loebinger, Sam M Janes
Seminars in Respiratory and Critical Care Medicine|July 14, 2021
Clinical and Radiological Phenotypes and EndotypesRicardo J José, Michael R Loebinger
Seminars in Respiratory and Critical Care Medicine|August 3, 2018
Diagnosis of Nontuberculous Mycobacteria Lung DiseaseSteven A Cowman, Michael R Loebinger
The Lancet. Respiratory Medicine|December 4, 2014
Non-cystic fibrosis bronchiectasis: an evidence-base for new therapiesDiana Bilton, Michael R Loebinger, Robert Wilson
Future Healthcare Journal|August 5, 2022
The role of wirelessly observed therapy in improving treatment adherenceKartik Kumar, Michael R Loebinger, Saira Ghafur
Clinical Science (London, England : 1979)|December 8, 2007
Therapeutic potential of stem cells in lung disease: progress and pitfallsMichael R Loebinger, Susana Aguilar, Sam M Janes
Thorax|December 18, 2012
Research priorities in bronchiectasisAnthony De Soyza, Jeremy Stuart Brown, Michael R Loebinger, et al.
Proceedings of the American Thoracic Society|August 8, 2008
Mesenchymal stem cells as vectors for lung diseaseMichael R Loebinger, Elizabeth K Sage, Sam M Janes
Cancer Research|May 14, 2009
Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancerMichael R Loebinger, Ayad Eddaoudi, Derek Davies, et al.
The European Respiratory Journal|June 22, 2019
Non-tuberculous mycobacterial pulmonary diseaseSteven Cowman, Jakko van Ingen, David E Griffith, et al.
Pageof 15